Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial

(MedPage Today) — NEW ORLEANS — Patients experiencing major heart attacks had a lower risk of serious complications if they received a single injection of the investigational drug zalunfiban at first medical contact, a randomized placebo-controlled…